Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$430M |
| 3 |
Verizon
VZ
|
+$390M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Broadcom
AVGO
|
+$212M |
Top Sells
| 1 |
iShares MBS ETF
MBB
|
+$560M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$537M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$144M |
| 4 |
Oracle
ORCL
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| 1 | Technology | 20.19% |
| 2 | Financials | 13.06% |
| 3 | Healthcare | 12.04% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Brookfield Renewable
BEPC
$6.05B
| $531K | ﹤0.01% |
12,650
-262,673
| -95% | -$11M |
|
|
HOFV
3152
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $531K | ﹤0.01% |
6,136
+5,300
| +634% | +$459K |
|
3153
Nathan's Famous
NATH
$437M
| $529K | ﹤0.01% |
7,416
+720
| +11% | +$51.4K |
|
3154
Kinetik
KNTK
$2.58B
| $528K | ﹤0.01% |
+15,616
| New | +$528K |
|
|
SEEL
3155
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $528K | ﹤0.01% |
52
+46
| +767% | +$467K |
|
3156
Alkami Technology
ALKT
$2.62B
| $527K | ﹤0.01% |
+14,756
| New | +$527K |
|
3157
Global Water Resources
GWRS
$266M
| $527K | ﹤0.01% |
30,851
-1,956
| -6% | -$33.4K |
|
3158
Ryvyl
RVYL
$9.17M
| $527K | ﹤0.01% |
+4,412
| New | +$527K |
|
|
ONCT
3159
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $521K | ﹤0.01% |
5,484
+4,691
| +592% | +$446K |
|
3160
Tiptree Inc
TIPT
$882M
| $519K | ﹤0.01% |
55,701
-5,935
| -10% | -$55.3K |
|
|
HBMD
3161
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $518K | ﹤0.01% |
32,095
-139
| -0.4% | -$2.24K |
|
|
OPTN
3162
DELISTED
OptiNose
OPTN
| $511K | ﹤0.01% |
10,950
-5,587
| -34% | -$261K |
|
3163
Adicet Bio
ACET
$66.9M
| $510K | ﹤0.01% |
+49,560
| New | +$510K |
|
3164
Cyclerion Therapeutics
CYCN
$7.57M
| $506K | ﹤0.01% |
6,481
-3,503
| -35% | -$273K |
|
|
BMTX
3165
DELISTED
BM Technologies, Inc.
BMTX
| $504K | ﹤0.01% |
43,364
| – | – |
|
3166
iShares Russell 1000 Value ETF
IWD
$63.4B
| $500K | ﹤0.01% |
3,150
-650
| -17% | -$103K |
|
3167
BeyondSpring
BYSI
$77M
| $496K | ﹤0.01% |
47,461
+6,915
| +17% | +$72.3K |
|
3168
HF Foods Group
HFFG
$171M
| $496K | ﹤0.01% |
93,756
| – | – |
|
3169
iRadimed
IRMD
$910M
| $496K | ﹤0.01% |
16,863
+1,140
| +7% | +$33.5K |
|
3170
Avalo Therapeutics
AVTX
$145M
| $494K | ﹤0.01% |
52
+7
| +16% | +$66.5K |
|
3171
Kezar Life Sciences
KZR
$29.3M
| $489K | ﹤0.01% |
9,001
+1,369
| +18% | +$74.4K |
|
3172
NextCure
NXTC
$14.7M
| $489K | ﹤0.01% |
5,073
-3,101
| -38% | -$299K |
|
|
PZN
3173
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $488K | ﹤0.01% |
44,276
+4,044
| +10% | +$44.6K |
|
|
EXTN
3174
DELISTED
Exterran Corporation
EXTN
| $488K | ﹤0.01% |
102,461
-65,271
| -39% | -$311K |
|
|
SPRB
3175
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $485K | ﹤0.01% |
43,229
-909
| -2% | -$10.2K |
|